AFTER months of suspense, the Higher Education Commission has a new leader. Though the status of the HEC as a regulator of higher education affairs is reasonably well-grounded, the Commission’s future ...

Dubai firefighters, robotic units contain Ras Al Khor blaze; no injuries reported Dubai: Dubai Civil Defence teams contained a warehouse fire in the Ras Al Khor industrial area within an hour on ...

Ras Kass returns with “Leopard Eats Face,” a feature-heavy Hip-Hop statement blending everything he is in one great project. Ras Kass: Man, the people on this album… I would be remiss, man. I’m gonna ...

NEW YORK--(BUSINESS WIRE)--TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC ...

TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North America, today announced that the Firm earned the #4 ranking on the HEC Paris-Dow Jones 2025 Global ...

Downers Grove, Ill.-based AllTranstek LLC has acquired the assets of Darien, Ill.-based RAS Data Services (RAS), following its identification last month as the prevailing auction bidder. AllTranstek, ...

#Pendant #Howtomake #Tutorial #LanAnhHandmade #Copperwire I make a bunny pendant, but sometimes it looks like a radish Timestamp 00:00 Preview, Materials and Tools 00:31 make a rabbit's head 03:28 ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Home equity contracts promise no payments but demand high end-term paybacks. Federal regulators warn HECs mirror risky loans from the 2008 housing crash. Rising home values and opaque terms raise long ...

Imagine this: you’re in the middle of an important project, juggling deadlines, and collaborating with a team scattered across time zones. Suddenly, your computer crashes, and hours of work vanish in ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.